Instrument free, disposable Point-Of-Care test for determining CD4 counts in HIV-infected patients.

Click here for further information.

Our Mission: To improve human health and well being through innovative diagnostic tests and global partnerships.

Omega is focused on selling a wide range of specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy and Autoimmune, Food Intolerance and Infectious Disease.

Final Results Interview

Interview between Kieron Harbinson and BRR Media on 7 July 2015 to discuss the year end 31 March 2015 results

Trading Update Interview

Interview between Kieron Harbinson, CFO and BRR Media on 15th April 2015 following the announcement of a Trading Update